World Journal of Diabetes

Papers
(The TQCC of World Journal of Diabetes is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Gut microbiota and diabetes: From correlation to causality and mechanism88
Diabetes and cancer: Epidemiological and biological links80
Role of ferroptosis in the process of diabetes-induced endothelial dysfunction72
Long-term metformin therapy and vitamin B12 deficiency: an association to bear in mind68
Diabetes and peripheral artery disease: A review58
Euglycemic diabetic ketoacidosis: A missed diagnosis57
Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action56
Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters51
Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention40
Effects of ketogenic diet and ketone bodies on the cardiovascular system: Concentration matters40
Role of insulin and insulin resistance in androgen excess disorders39
Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis38
New insights into renal lipid dysmetabolism in diabetic kidney disease36
Management of diabetic foot ulcers and the challenging points: An endocrine view35
Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review34
Novel insight into perirenal adipose tissue: A neglected adipose depot linking cardiovascular and chronic kidney disease33
Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop33
Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review33
Anti-diabetics and antimicrobials: Harmony of mutual interplay31
Diabetic heart disease: A clinical update29
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links29
Interstitial lung disease and diabetes28
Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications28
Cognitive disorder and dementia in type 2 diabetes mellitus27
Diabetes remission after bariatric surgery27
Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review26
Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents26
Diabetic foot ulcers: Classification, risk factors and management25
Cardiac changes in infants of diabetic mothers24
Markers of insulin resistance in Polycystic ovary syndrome women: An update24
Diabetic gastroenteropathy: An underdiagnosed complication23
Spatial epidemiology of diabetes: Methods and insights23
Estrogens and the regulation of glucose metabolism23
Diabetes-induced changes in cardiac voltage-gated ion channels23
Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products22
Comprehensive overview of human serum albumin glycation in diabetes mellitus22
Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress21
Age of onset of diabetes and all-cause mortality20
Role of novel biomarkers in diabetic cardiomyopathy20
Diabetes and gut microbiota20
Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure19
Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients18
Fetal programming of obesity and type 2 diabetes18
Prevalence and impact of diabetes in patients with COVID-19 in China17
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice16
Obesity, metabolic health and omics: Current status and future directions16
Progress on haptoglobin and metabolic diseases16
Diabetic foot ulcer: Challenges and future16
Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity16
Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives16
Novel glucose-lowering drugs for non-alcoholic fatty liver disease15
Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities15
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?15
Modulatory effect of caffeic acid in alleviating diabetes and associated complications15
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment15
Mechanisms linking gut microbial metabolites to insulin resistance14
Malfunction of outer retinal barrier and choroid in the occurrence and progression of diabetic macular edema14
Oral glucose tolerance test in diabetes, the old method revisited14
Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes14
Psychosocial factors affecting the etiology and management of type 1 diabetes mellitus: A narrative review13
Sugar intake from sweetened beverages and diabetes: A narrative review13
Maternal obesity as a risk factor for developing diabetes in offspring: An epigenetic point of view13
Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus13
Obesity and bariatric surgery in kidney transplantation: A clinical review13
Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signaling13
Humanin and diabetes mellitus: A review of in vitro and in vivo studies13
Evolving spectrum of diabetic wound: Mechanistic insights and therapeutic targets13
Range of adiposity and cardiorenal syndrome12
Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review12
Insulin-resistance in paediatric age: Its magnitude and implications12
Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis12
Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway12
Ejaculatory dysfunction in men with diabetes mellitus12
The role of artificial intelligence technology in the care of diabetic foot ulcers: the past, the present, and the future12
Glargine-300: An updated literature review on randomized controlled trials and real-world studies12
p66Shc-mediated oxidative stress is involved in gestational diabetes mellitus12
COVID-19 and hyperglycemia/diabetes12
Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor12
Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes12
Gut microbiota-derived metabolites are novel targets for improving insulin resistance11
Combination therapy of hydrogel and stem cells for diabetic wound healing11
Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus11
Current progress in metabolomics of gestational diabetes mellitus11
Management of diabesity: Current concepts11
Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus11
Holistic perspective of the role of gut microbes in diabetes mellitus and its management11
Potential role of Limosilactobacillus fermentum as a probiotic with anti-diabetic properties: A review11
Telerehabilitation intervention for type 2 diabetes10
Glycemic targets in critically ill adults: A mini-review10
Inflammatory bowel disease and diabetes: Is there a link between them?10
Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy10
Progress in treatment of type 2 diabetes by bariatric surgery10
Perioperative challenges in management of diabetic patients undergoing non-cardiac surgery10
Current cancer therapies and their influence on glucose control10
Role of interferons in diabetic retinopathy10
Access to insulin delivery devices and glycated haemoglobin in lower-income countries10
Protective effects of physical activity against health risks associated with type 1 diabetes: “Health benefits outweigh the risks”9
Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: A multicenter retrospective cohort study9
Diabetes and COVID-19: Diseases of racial, social and glucose intolerance9
Mesenchymal stem cell-derived exosomes: The dawn of diabetic wound healing9
Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response9
Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice9
Diabetes in French Guiana, adapting national standards of therapeutic education and care to the amazonian challenge9
Effectiveness of cognitive behavior therapy for sleep disturbance and glycemic control in persons with type 2 diabetes mellitus: A community-based randomized controlled trial in China9
What’s old is new again: Insights into diabetic foot microbiome9
COVID-19 associated diabetes mellitus: A review9
Type 1 diabetes and associated autoimmune diseases9
Impact of diabetes mellitus and cardiometabolic syndrome on the risk of Alzheimer’s disease among postmenopausal women9
Chronic care model in the diabetes pay-for-performance program in Taiwan: Benefits, challenges and future directions9
Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients9
Acarbose is again on the stage9
Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy9
Organophosphate pesticides and new-onset diabetes mellitus: From molecular mechanisms to a possible therapeutic perspective9
Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus9
Vanadium-dependent activation of glucose transport in adipocytes by catecholamines is not mediatedviaadrenoceptor stimulation or monoamine oxidase activity8
Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence8
Interactions between diabetes and COVID-19: A narrative review8
Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study8
Exercise intervention under hypoxic condition as a new therapeutic paradigm for type 2 diabetes mellitus: A narrative review8
Type 1 diabetes mellitus and its oral tolerance therapy8
Altered spontaneous brain activity in patients with diabetic optic neuropathy: A resting-state functional magnetic resonance imaging study using regional homogeneity8
Immunometabolic bases of type 2 diabetes in the severity of COVID-198
Overcoming ischemia in the diabetic foot: Minimally invasive treatment options8
0.023694038391113